We are live on ! Find out more
TBIO

Translate Bio, Inc. Common Stock
TBIO

Delisted

TBIO was delisted on the 13th of September, 2021.

67 hedge funds and large institutions have $521M invested in Translate Bio, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 28 increasing their positions, 7 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 7

78% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 9

12% more capital invested

Capital invested by funds: $466M → $521M (+$55.1M)

12% more funds holding

Funds holding: 6067 (+7)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

Holders
67
Holders Change
+7
Holders Change %
+11.67%
% of All Funds
1.47%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
16
Increased
28
Reduced
7
Closed
9
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
MFG
26
Magnus Financial Group
New York
$702K
MWNA
27
Marshall Wace North America
New York
$451K +$429K +45,472 New
California State Teachers Retirement System (CalSTRS)
28
California State Teachers Retirement System (CalSTRS)
California
$448K
State of Wisconsin Investment Board
29
State of Wisconsin Investment Board
Wisconsin
$425K
RhumbLine Advisers
30
RhumbLine Advisers
Massachusetts
$368K -$2.27K -240 -0.6%
New York State Common Retirement Fund
31
New York State Common Retirement Fund
New York
$297K
AllianceBernstein
32
AllianceBernstein
Tennessee
$270K +$51.9K +5,500 +25%
Goldman Sachs
33
Goldman Sachs
New York
$269K -$380K -40,196 -60%
GCP
34
GSA Capital Partners
United Kingdom
$222K +$211K +22,359 New
RJA
35
Raymond James & Associates
Florida
$195K +$186K +19,670 New
Manulife (Manufacturers Life Insurance)
36
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$194K +$1.38K +146 +0.8%
AIG
37
American International Group
New York
$184K -$1.22K -129 -0.7%
Barclays
38
Barclays
United Kingdom
$183K -$4.01K -425 -2%
LCM
39
Laurion Capital Management
New York
$173K +$165K +17,500 New
ProShare Advisors
40
ProShare Advisors
Maryland
$170K -$7.81K -827 -5%
Bank of America
41
Bank of America
North Carolina
$163K +$48.5K +5,141 +45%
MIM
42
MetLife Investment Management
New Jersey
$160K
Wells Fargo
43
Wells Fargo
California
$152K +$7.83K +829 +6%
UBS Group
44
UBS Group
Switzerland
$148K +$133K +14,104 +1,669%
Susquehanna International Group
45
Susquehanna International Group
Pennsylvania
$144K +$27.8K +2,940 +25%
California Public Employees Retirement System
46
California Public Employees Retirement System
California
$141K +$33.9K +3,586 +34%
FAAS
47
First Allied Advisory Services
California
$129K +$123K +13,000 New
Squarepoint
48
Squarepoint
New York
$128K +$122K +12,914 New
VOYA Investment Management
49
VOYA Investment Management
Georgia
$119K
MLICM
50
Metropolitan Life Insurance Company (MetLife)
New York
$116K

TBIO Hedge Fund Activity: Q3 2019 in Review

67 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Translate Bio, Inc. Common Stock (TBIO) for Q3 2019, worth a combined $521M — up 12% from $466M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new TBIO positions and 9 closed out — a net gain of 7 holders — while 28 added to existing stakes and 7 trimmed.

The largest buyer was Baupost Group, adding an estimated $82.1M. The largest seller was Highbridge Capital Management, cutting an estimated $1.32M.

  • 67 institutional investors held Translate Bio, Inc. Common Stock (TBIO) as of Q3 2019, up from 60 in Q2 2019.
  • Funds reported $521M of Translate Bio, Inc. Common Stock stock for Q3 2019, up 12% quarter-over-quarter.
  • 16 funds opened new Translate Bio, Inc. Common Stock positions in Q3 2019 and 9 closed out, a net change of +7 holders.
  • The largest Translate Bio, Inc. Common Stock buyer in Q3 2019 was Baupost Group, an estimated $82.1M added.
  • The largest Translate Bio, Inc. Common Stock seller in Q3 2019 was Highbridge Capital Management, an estimated $1.32M sold.

Based on aggregated 13F filings for Q3 2019.